Download Files:
Apitegromab
Price range: 355 CAD through 1,579 CAD
Products Details
Product Description
– Apitegromab (SRK-015) is a new myostatin inhibitor, an antibody targeting myostatin precursor, which can be used to study neuromuscular diseases including spinal muscular atrophy.
Web ID
– T77445
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Doreen Barrett, et al. A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy. Adv Ther. 2021 Jun;38(6):3203-3222.
CAS Number
– 2278276-46-1
Compound Purity
– 97.59% (SDS-PAGE); 99.78% (SEC-HPLC)
Pathway
– Neuroscience|||Endocrinology/Hormones|||GPCR/G Protein
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
